NeoGenomics, Inc. (NEO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SERVICES-TESTING LABORATORIES

12701 COMMONWEALTH DRIVE FORT MYERS, FL 33913

NeoGenomics operates a network of cancer-focused testing laboratories that provides genetic and molecular testing services, including: Cytogenetics testing, which studies normal and abnormal chromosomes and their relationship to disease; Fluorescence In-Situ Hybridization testing, which detects and locates the presence or absence of certain deoxyribonucleic acid (DNA) sequences and genes on chromosomes; flow cytometry testing, which measures the characteristics of cell populations; immunohistochemistry testing, which identifies cell proteins in a tissue section; and molecular testing, which analyzes the DNA and ribonucleic, and the structure and function of genes at a molecular level.

Data based on most recent fiscal year report
Market Cap651.321 Million Shares Outstanding80.41 Million Avg Volume553.223 Thousand
1-Yr BETA vs S&P TR0 Current Ratio2.42 Quick Ratio2.21
View SEC Filings from NEO instead.
Q2 2019 All Institutions Hedge Funds 1
To trade NEO now:
Filers who had this stock in their top 10: 9 2 (0.21%)
13F Filers holding this stock: 248 25 (2.58%)
Aggregate 13F shares on 06/30/2019: 88.1 Million 5.405 Million
Aggregate 13F shares on 03/31/2019: 80.43 Million 5.48 Million
Percent change: 9.54% -1.37%
Funds creating new positions: 40 8
Funds Adding to an existing position: 109 10
Funds closing out their position: 22 3
Funds reducing their position: 67 7
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NEO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

311 Thousand total shares from 13 transactions

Exercise Derivative Conversion (M)

37.8 Thousand total shares from 6 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CROWTHER BRUCE K

  • Director
34,503 2019-09-30 1

MURPHY KIERAN PIUS SENIOR VICE PRESIDENT

  • Officer
94,205 2019-09-11 0

HANNAH ALISON L.

  • Director
76,098 2019-09-09 2

JONES STEVEN C

  • Director
488,767 2019-09-06 6

VAN OORT DOUGLAS M CHAIRMAN AND CEO

  • Officer
  • Director
2,214,089 2019-08-28 3

BONELLO WILLIAM CHIEF STRATEGY OFFICER

  • Officer
6,735 2019-08-28 4

HIPP RAYMOND R

  • Director
134,102 2019-08-23 4

JOHNSON KEVIN C

  • Director
28,285 2019-08-23 5

TETRAULT LYNN A.

  • Director
41,653 2019-06-06 3

KANOVSKY STEPHEN M

  • Director
3,419 2019-06-06 1

SHOVLIN ROBERT J. PRESIDENT, CLINICAL SERVICES

  • Officer
155,748 2019-05-25 5

CARDOZA GEORGE PRESIDENT, PHARMA SERVICES

  • Officer
320,831 2019-05-02 3

BALLIET JENNIFER VP AND CHIEF CULTURE OFFICER

  • Officer
22,862 2019-05-02 4

MCKENZIE KATHRYN B PRINCIPAL ACCOUNTING OFFICER

  • Officer
2,273 2019-03-01 1

VIRAG SHARON CHIEF FINANCIAL OFFICER

  • Officer
10,944 2019-03-01 1

WEISS LAWRENCE MARTIN CHIEF SCIENTIFIC OFFICER

  • Officer
5,893 2019-03-01 3

GENERAL ELECTRIC CO

GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC.

  • FORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2018-12-14 2

BRODIE STEVEN G. VP - PHARMA OPERATIONS

  • Officer
45,953 2018-10-22 1

ROSS STEVEN A CIO

  • Officer
9,000 2018-05-10 0

BYWATER STEPHANIE K CHIEF COMPLIANCE OFFICER

  • Officer
528 2018-05-01 0

DENT MICHAEL T CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
  • 10% Owner
0 2018-02-15 0

ROBISON WILLIAM J

  • Director
359,474 2017-05-25 0

ALBITAR MAHER CHIEF MEDICAL OFFICER

  • Officer
60,692 2017-04-28 0

MACHULCZ MARK ALAN VICE PRESIDENT OF OPERATIONS

  • Officer
0 2016-01-28 0

HOREL ROBERT H. VICE PRESIDENT GM PATHLOGIC

  • Officer
51,218 2015-12-29 0

JONES STEVEN C EXECUTIVE VP OF FINANCE

ASPEN SELECT HEALTHCARE LP

  • Officer
  • 10% Owner
3,886,629 2015-11-25 0

SMITS MARK W SVP-COMMERCIAL OPERATIONS

  • Officer
9,608 2015-06-01 0

GASPARINI ROBERT P CHIEF SCIENCE OFFICER

  • Officer
8,439 2014-05-22 0

KINDERHOOK, LP

KINDERHOOK GP LLC

KINDERHOOK PARTNERS, LLC

SHAH TUSHAR

CLEARMAN STEPHEN J

  • 10% Owner
5,459,517 2014-01-09 0

DVONCH JEROME J PRINICPAL ACCOUNTING OFFICER

  • Officer
0 2011-05-02 0

MILLER MARYDAWN VICE PRESIDENT OF IT

  • Officer
0 2011-05-02 0

PETERSON PETER M

  • Director
  • 10% Owner
8,191,550 2011-05-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

JONES STEVEN C - Director shares owned in ira, custodian accounts, and trusts for the family of steven jones

2019-09-10 G 3,400 d 43,057 488,767.00 indirect

JONES STEVEN C - Director shares owned in ira, custodian accounts, and trusts for the family of steven jones

2019-09-10 S 1,200 $21.47 d 46,457 488,767.00 indirect

HANNAH ALISON L. - Director

2019-09-09 M 8,333 $9.11 d 0 76,098.00 direct

HANNAH ALISON L. - Director

2019-09-09 M 3,333 $6.66 a 67,765 76,098.00 direct

JONES STEVEN C - Director by aspen select opportunity fund

2019-09-09 S 3 $25.00 d 1,676,230 488,767.00 indirect

HANNAH ALISON L. - Director

2019-09-09 M 3,333 $6.66 d 0 76,098.00 direct

HANNAH ALISON L. - Director

2019-09-09 M 8,333 $9.11 a 76,098 76,098.00 direct

JONES STEVEN C - Director by aspen select opportunity fund

2019-09-06 S 1,691 $25.00 d 1,676,233 488,767.00 indirect

JONES STEVEN C - Director by aspen select opportunity fund

2019-08-30 S 1,200 $25.00 d 1,677,924 2,171,291.00 indirect

VAN OORT DOUGLAS M - Director - Officer CHAIRMAN AND CEO

2019-08-29 G 10,000 d 2,016,589 2,214,089.00 direct

VAN OORT DOUGLAS M - Director - Officer CHAIRMAN AND CEO custodial account for child

2019-08-28 G 10,000 a 10,000 2,214,089.00 indirect

BONELLO WILLIAM - Officer CHIEF STRATEGY OFFICER

2019-08-28 S 17,000 $24.83 d 6,735 6,735.00 direct

VAN OORT DOUGLAS M - Director - Officer CHAIRMAN AND CEO

2019-08-28 G 10,000 d 2,026,589 2,214,089.00 direct

JONES STEVEN C - Director by aspen select opportunity fund

2019-08-28 S 39,537 $25.02 d 1,679,124 2,171,291.00 indirect

BONELLO WILLIAM - Officer CHIEF STRATEGY OFFICER

2019-08-28 M 17,000 $7.52 a 23,735 6,735.00 direct

VAN OORT DOUGLAS M - Director - Officer CHAIRMAN AND CEO

2019-08-28 G 30,000 d 2,036,589 2,214,089.00 direct

BONELLO WILLIAM - Officer CHIEF STRATEGY OFFICER

2019-08-28 M 17,000 d 55,763 6,735.00 direct

JONES STEVEN C - Director by aspen select opportunity fund

2019-08-27 S 30,280 $24.95 d 1,718,661 2,212,028.00 indirect

HIPP RAYMOND R - Director

2019-08-26 S 15,424 $24.79 d 134,102 134,102.00 direct

JONES STEVEN C - Director by aspen select opportunity fund

2019-08-26 S 143,603 $24.87 d 1,748,941 2,212,028.00 indirect

JOHNSON KEVIN C - Director

2019-08-26 S 11,800 $24.74 d 28,285 28,285.00 direct

JONES STEVEN C - Director by aspen select opportunity fund

2019-08-23 S 7,456 $25.72 d 1,892,544 2,212,028.00 indirect

JOHNSON KEVIN C - Director

2019-08-23 S 41,200 $25.60 d 40,085 28,285.00 direct

HIPP RAYMOND R - Director

2019-08-23 M 2,777 d 0 134,102.00 direct

HIPP RAYMOND R - Director

2019-08-23 M 2,777 $9.11 a 150,126 134,102.00 direct

HIPP RAYMOND R - Director

2019-08-23 M 3,017 d 0 134,102.00 direct

HIPP RAYMOND R - Director

2019-08-23 M 3,333 $7.27 a 147,349 134,102.00 direct

HIPP RAYMOND R - Director

2019-08-23 M 3,333 d 3,334 134,102.00 direct

HIPP RAYMOND R - Director

2019-08-23 S 600 $25.02 d 149,526 134,102.00 direct

HIPP RAYMOND R - Director

2019-08-23 M 3,017 $11.60 a 144,016 134,102.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments